Figure 8.The UPR-related predictive signature for stomach cancer patients. (A) Disease-specific survival among different groups and (B) the ROC for disease-specific survival prediction. (C) Disease-free survival among different groups and (D) the ROC for disease-free survival prediction. (E) Progression-free survival among different groups and (F) the ROC for progression-free survival prediction.
